Lataa...
Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema
BACKGROUND/AIMS: Bevacizumab and ranibizumab are routinely used to treat diabetic macular edema (DME). We aim to evaluate the usefulness of switching to ranibizumab therapy following bevacizumab treatment failure in eyes with DME. METHODS: We performed a retrospective analysis of a consecutive group...
Tallennettuna:
| Julkaisussa: | Case Rep Ophthalmol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
S. Karger AG
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4357677/ https://ncbi.nlm.nih.gov/pubmed/25802504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000375230 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|